Swedish Orphan (Germany) Analysis
| B6E Stock | EUR 26.86 0.42 1.59% |
Swedish Orphan Biovitrum is overvalued with Real Value of 22.8 and Hype Value of 26.86. The main objective of Swedish Orphan stock analysis is to determine its intrinsic value, which is an estimate of what Swedish Orphan Biovitrum is worth, separate from its market price. There are two main types of Swedish Orphan's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Swedish Orphan's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Swedish Orphan's stock to identify patterns and trends that may indicate its future price movements.
The Swedish Orphan stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Swedish Orphan's ongoing operational relationships across important fundamental and technical indicators.
Swedish |
Swedish Stock Analysis Notes
About 70.0% of the company shares are held by institutions such as insurance companies. The book value of Swedish Orphan was currently reported as 3.55. The company had not issued any dividends in recent years. Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, immunology, and genetic and metabolic diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. SWEDISH ORPHAN is traded on Frankfurt Stock Exchange in Germany. For more info on Swedish Orphan Biovitrum please contact Guido Oelkers at 46 86 97 20 00 or go to https://www.sobi.com.Swedish Orphan Biovitrum Investment Alerts
| Swedish Orphan generated a negative expected return over the last 90 days | |
| Swedish Orphan Biovitrum has accumulated 8.78 B in total debt with debt to equity ratio (D/E) of 39.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Swedish Orphan Biovitrum has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Swedish Orphan until it has trouble settling it off, either with new capital or with free cash flow. So, Swedish Orphan's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Swedish Orphan Biovitrum sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Swedish to invest in growth at high rates of return. When we think about Swedish Orphan's use of debt, we should always consider it together with cash and equity. | |
| About 70.0% of Swedish Orphan shares are held by institutions such as insurance companies |
Swedish Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Swedish Orphan's market, we take the total number of its shares issued and multiply it by Swedish Orphan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Swedish Profitablity
Swedish Orphan's profitability indicators refer to fundamental financial ratios that showcase Swedish Orphan's ability to generate income relative to its revenue or operating costs. If, let's say, Swedish Orphan is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Swedish Orphan's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Swedish Orphan's profitability requires more research than a typical breakdown of Swedish Orphan's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Technical Drivers
As of the 26th of December, Swedish Orphan has the Variance of 5.24, risk adjusted performance of (0.01), and Coefficient Of Variation of (4,743). Swedish Orphan technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Swedish Orphan Biovitrum mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Swedish Orphan is priced more or less accurately, providing market reflects its prevalent price of 26.86 per share.Swedish Orphan Biovitrum Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Swedish Orphan middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Swedish Orphan Biovitrum. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Swedish Orphan Outstanding Bonds
Swedish Orphan issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Swedish Orphan Biovitrum uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Swedish bonds can be classified according to their maturity, which is the date when Swedish Orphan Biovitrum has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Swedish Orphan Predictive Daily Indicators
Swedish Orphan intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Swedish Orphan stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 26.86 | |||
| Day Typical Price | 26.86 | |||
| Price Action Indicator | 0.21 | |||
| Period Momentum Indicator | 0.42 | |||
| Relative Strength Index | 52.56 |
Swedish Orphan Forecast Models
Swedish Orphan's time-series forecasting models are one of many Swedish Orphan's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Swedish Orphan's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Swedish Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Swedish Orphan prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Swedish shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Swedish Orphan. By using and applying Swedish Stock analysis, traders can create a robust methodology for identifying Swedish entry and exit points for their positions.
Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, immunology, and genetic and metabolic diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. SWEDISH ORPHAN is traded on Frankfurt Stock Exchange in Germany.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Swedish Orphan to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Complementary Tools for Swedish Stock analysis
When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |